Cargando…
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
BACKGROUND: Cancer-related weight loss is associated with increased inflammation and decreased survival. The novel inflammatory mediator growth differentiation factor (GDF)15 is associated with poor prognosis in cancer but its role in cancer-related weight loss (C-WL) remains unclear. Our objective...
Autores principales: | Lerner, Lorena, Hayes, Teresa G, Tao, Nianjun, Krieger, Brian, Feng, Bin, Wu, Zhenhua, Nicoletti, Richard, Chiu, M Isabel, Gyuris, Jeno, Garcia, Jose M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670740/ https://www.ncbi.nlm.nih.gov/pubmed/26672741 http://dx.doi.org/10.1002/jcsm.12033 |
Ejemplares similares
-
MAP3K11/GDF15 axis is a critical driver of cancer cachexia
por: Lerner, Lorena, et al.
Publicado: (2015) -
Weight Loss and Mortality
Publicado: (2005) -
Interleukin-15 Treatment Induces Weight Loss Independent of Lymphocytes
por: Barra, Nicole G., et al.
Publicado: (2012) -
GDF15 promotes weight loss by enhancing energy expenditure in muscle
por: Wang, Dongdong, et al.
Publicado: (2023) -
Alterations of Plasma Lysophosphatidylcholine Species in Obesity and Weight Loss
por: Heimerl, Susanne, et al.
Publicado: (2014)